New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan
Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-h...
Saved in:
Published in | International journal of molecular sciences Vol. 24; no. 11; p. 9155 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
23.05.2023
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC50 in low micromolar or nanomolar ranges. Geraniol derivative 33a was the most potent inhibitor with IC50 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered. |
---|---|
AbstractList | Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC50 in low micromolar or nanomolar ranges. Geraniol derivative 33a was the most potent inhibitor with IC50 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered. Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC[sub.50] in low micromolar or nanomolar ranges. Geraniol derivative 33a was the most potent inhibitor with IC[sub.50] 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered. Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC in low micromolar or nanomolar ranges. Geraniol derivative was the most potent inhibitor with IC 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered. Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC 50 in low micromolar or nanomolar ranges. Geraniol derivative 33a was the most potent inhibitor with IC 50 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered. Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC50 in low micromolar or nanomolar ranges. Geraniol derivative 33a was the most potent inhibitor with IC50 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered.Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a topoisomerase 1 poison such as the anticancer drug topotecan makes TDP1 a promising target for complex antitumor therapy. In this work, a set of new 5-hydroxycoumarin derivatives containing monoterpene moieties was synthesized. It was shown that most of the conjugates synthesized demonstrated high inhibitory properties against TDP1 with an IC50 in low micromolar or nanomolar ranges. Geraniol derivative 33a was the most potent inhibitor with IC50 130 nM. Docking the ligands to TDP1 predicted a good fit with the catalytic pocket blocking access to it. The conjugates used in non-toxic concentration increased cytotoxicity of topotecan against HeLa cancer cell line but not against conditionally normal HEK 293A cells. Thus, a new structural series of TDP1 inhibitors, which are able to sensitize cancer cells to the topotecan cytotoxic effect has been discovered. |
Audience | Academic |
Author | Zakharenko, Alexandra L. Korchagina, Dina V. Lavrik, Olga I. Dyrkheeva, Nadezhda S. Artemova, Anastasia O. Salakhutdinov, Nariman F. Chepanova, Arina A. Curtis, Anthony Khomenko, Tatyana M. Reynisson, Jóhannes Volcho, Konstantin P. Achara, Chigozie Kornienko, Tatyana E. |
AuthorAffiliation | 2 Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia dyrkheeva.n.s@gmail.com (N.S.D.) 3 School of Pharmacy and Bioengineering, Keele University, Hornbeam Building, Newcastle-under-Lyme, Staffordshire ST5 5BG, UK a.d.m.curtis@keele.ac.uk (A.C.); j.reynisson@keele.ac.uk (J.R.) 1 N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia; chomenko@nioch.nsc.ru (T.M.K.) |
AuthorAffiliation_xml | – name: 1 N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia; chomenko@nioch.nsc.ru (T.M.K.) – name: 2 Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia dyrkheeva.n.s@gmail.com (N.S.D.) – name: 3 School of Pharmacy and Bioengineering, Keele University, Hornbeam Building, Newcastle-under-Lyme, Staffordshire ST5 5BG, UK a.d.m.curtis@keele.ac.uk (A.C.); j.reynisson@keele.ac.uk (J.R.) |
Author_xml | – sequence: 1 givenname: Tatyana M. surname: Khomenko fullname: Khomenko, Tatyana M. – sequence: 2 givenname: Alexandra L. surname: Zakharenko fullname: Zakharenko, Alexandra L. – sequence: 3 givenname: Tatyana E. surname: Kornienko fullname: Kornienko, Tatyana E. – sequence: 4 givenname: Arina A. surname: Chepanova fullname: Chepanova, Arina A. – sequence: 5 givenname: Nadezhda S. orcidid: 0000-0002-8360-1041 surname: Dyrkheeva fullname: Dyrkheeva, Nadezhda S. – sequence: 6 givenname: Anastasia O. surname: Artemova fullname: Artemova, Anastasia O. – sequence: 7 givenname: Dina V. surname: Korchagina fullname: Korchagina, Dina V. – sequence: 8 givenname: Chigozie surname: Achara fullname: Achara, Chigozie – sequence: 9 givenname: Anthony orcidid: 0000-0003-0445-2234 surname: Curtis fullname: Curtis, Anthony – sequence: 10 givenname: Jóhannes orcidid: 0000-0003-4174-9512 surname: Reynisson fullname: Reynisson, Jóhannes – sequence: 11 givenname: Konstantin P. orcidid: 0000-0002-4083-9324 surname: Volcho fullname: Volcho, Konstantin P. – sequence: 12 givenname: Nariman F. surname: Salakhutdinov fullname: Salakhutdinov, Nariman F. – sequence: 13 givenname: Olga I. orcidid: 0000-0001-5980-8889 surname: Lavrik fullname: Lavrik, Olga I. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37298106$$D View this record in MEDLINE/PubMed |
BookMark | eNptkktv1DAURi1URB-wY40ssWFBih9J7KzQMDw60qggMawtx77peJTYg50Aw6_HQ1uYVpUXtuxzv6uj61N05IMHhJ5Tcs55Q964zZBYSWlDq-oROqElYwUhtTg6OB-j05Q2hDDOquYJOuaCNZKS-gQNl_ATV8XFzsbwa2fCNOjofPFOJ7B4tYsh7fri_eUMf1mHtF0H6yCNEPMzXuCFX7vWjSEm_BV8cqP7DXg1DSHiOfQ9XjoPeAx4FbZhBKP9U_S4032CZzf7Gfr28cNqflEsP39azGfLwpSSjAVAJ2tGbclKpluwuqNtqZkwWhrW1ZxXvOmkoVQI2toGWGW5pcQ2EjrTCs3P0Nvr3O3UDmAN-DHqXm2jy3o7FbRTd1-8W6ur8ENRwipOa5oTXt0kxPB9ys5qcMlkKe0hTEkxycpaNqIhGX15D92EKfrs95cipail_E9d6R6U813Ijc0-VM1ExURJKrJve_4AlZeFwZk8-M7l-zsFLw5N_yneTjgD7BoweZYpQqeMG_Xowl7c9dlY7b-ROvxGuej1vaLb3AfxP5HSyUI |
CitedBy_id | crossref_primary_10_3390_life13102086 crossref_primary_10_1002_ardp_202400801 crossref_primary_10_3390_genes14101931 crossref_primary_10_59761_RCR5125 |
Cites_doi | 10.1039/C6CP01555G 10.1021/ja00205a002 10.2174/092986712802002590 10.1039/P29930000187 10.1021/jm001044l 10.1007/s00044-023-03025-x 10.1074/jbc.M405042200 10.3390/molecules26020501 10.1038/sj.emboj.7601885 10.3390/ijms24043834 10.1023/A:1007996124545 10.20944/preprints202209.0330.v1 10.1002/ddr.21639 10.3390/molecules26195999 10.3390/molecules28062673 10.1021/ja00205a003 10.1002/cmdc.202200593 10.3390/biom11070973 10.3109/03602532.2014.971957 10.1016/j.dnarep.2014.03.020 10.3389/fcell.2020.604732 10.1021/ci800298z 10.1016/j.dnarep.2009.02.002 10.1016/j.jmb.2007.07.055 10.1039/D2CB00230B 10.1016/j.bmcl.2022.128909 10.1002/prot.20588 10.1021/acs.jnatprod.6b00979 10.1016/j.bmc.2015.03.020 10.1073/pnas.93.21.11534 10.1038/nsb1203-980 10.3390/molecules28052413 10.3390/ijms24043799 10.3390/ijms21010126 10.3390/molecules26216755 10.1002/minf.201200103 10.3390/molecules26247493 10.1002/qsar.200730051 10.1007/s10517-019-04413-3 10.3390/molecules25153496 10.1006/jmbi.1996.0897 10.1021/ja00205a001 10.1016/j.ejmech.2018.10.055 10.3390/molecules26113128 10.3390/molecules23102468 10.1016/0022-1759(83)90303-4 10.1016/j.bmc.2016.09.016 10.1038/sj.emboj.7601869 10.1038/sj.emboj.7600694 10.1039/D0SC05411A 10.1007/s00280-003-0717-6 10.1002/prot.10465 10.3390/molecules28010323 10.3390/ijms24065781 10.1016/j.steroids.2020.108771 10.4172/1948-5956.1000280 10.1007/s10585-021-10113-y 10.3390/molecules27113374 10.1016/j.bcp.2011.09.021 10.3389/fchem.2022.910953 10.1093/nar/28.1.235 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.3390/ijms24119155 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | PMC10253161 A752740501 37298106 10_3390_ijms24119155 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Russian Science Foundation grantid: 19-13-00040 |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI GROUPED_DOAJ HCIFZ KB. M7P M~E NPM PDBOC PMFND 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c480t-eef8621d4242abedaf1b4a27ca8c2f633539f8c11771bd9e25d3d10d98efcb7a3 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Thu Aug 21 18:37:54 EDT 2025 Thu Jul 10 18:19:43 EDT 2025 Sat Aug 23 12:25:31 EDT 2025 Tue Jun 17 21:23:11 EDT 2025 Tue Jun 10 20:15:16 EDT 2025 Wed Feb 19 02:23:37 EST 2025 Tue Jul 01 02:04:16 EDT 2025 Thu Apr 24 22:55:19 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | monoterpene synergy enzyme inhibition DNA repair coumarin |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c480t-eef8621d4242abedaf1b4a27ca8c2f633539f8c11771bd9e25d3d10d98efcb7a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4083-9324 0000-0002-8360-1041 0000-0003-4174-9512 0000-0003-0445-2234 0000-0001-5980-8889 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms24119155 |
PMID | 37298106 |
PQID | 2824047688 |
PQPubID | 2032341 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10253161 proquest_miscellaneous_2824689790 proquest_journals_2824047688 gale_infotracmisc_A752740501 gale_infotracacademiconefile_A752740501 pubmed_primary_37298106 crossref_citationtrail_10_3390_ijms24119155 crossref_primary_10_3390_ijms24119155 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-05-23 |
PublicationDateYYYYMMDD | 2023-05-23 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2023 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Perego (ref_13) 2012; 83 Zhu (ref_52) 2012; 31 Katyal (ref_8) 2007; 26 Jones (ref_44) 1997; 267 Kavetsou (ref_37) 2020; 81 ref_58 Zakharenko (ref_41) 2015; 23 Zakharenko (ref_15) 2019; 161 Barthelmes (ref_10) 2004; 279 He (ref_6) 2007; 372 Zhao (ref_42) 2021; 12 Lii (ref_60) 1989; 111 ref_18 Berman (ref_56) 2000; 28 Zhao (ref_19) 2022; 10 Ioakimidis (ref_64) 2008; 27 Eldridge (ref_45) 1997; 11 ref_25 ref_24 ref_23 ref_22 ref_63 ref_62 Bissantz (ref_50) 2000; 43 ref_28 ref_27 Berman (ref_57) 2003; 10 Yildirim (ref_33) 2023; 32 Nikolin (ref_17) 2021; 38 Lii (ref_61) 1989; 111 Zakharenko (ref_51) 2016; 79 Koldysheva (ref_16) 2019; 166 Meisenberg (ref_14) 2014; 6 ref_36 ref_35 ref_34 Khomenko (ref_29) 2016; 24 ref_32 Yang (ref_2) 1996; 93 ref_31 Dyrkheeva (ref_54) 2020; 8 ref_30 Katyal (ref_9) 2009; 8 Mooij (ref_48) 2005; 61 Nivens (ref_11) 2004; 53 Pommier (ref_3) 2014; 19 ref_39 ref_38 Alagoz (ref_12) 2012; 19 Allinger (ref_59) 1989; 111 Hirano (ref_5) 2007; 26 Verdonk (ref_46) 2003; 52 Ivankin (ref_26) 2022; 73 Salomatina (ref_21) 2021; 165 Mosmann (ref_55) 1983; 65 Comeaux (ref_1) 2014; 46 ref_43 Yang (ref_4) 2023; 18 ref_40 Eurtivong (ref_53) 2018; 37 Wang (ref_49) 2016; 18 Interthal (ref_7) 2005; 24 Korb (ref_47) 2009; 49 Zhao (ref_20) 2023; 4 |
References_xml | – volume: 18 start-page: 12964 year: 2016 ident: ref_49 article-title: Comprehensive Evaluation of Ten Docking Programs on a Diverse Set of Protein–ligand Complexes: The Prediction Accuracy of Sampling Power and Scoring Power publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/C6CP01555G – volume: 111 start-page: 8566 year: 1989 ident: ref_60 article-title: Molecular Mechanics. The MM3 FOrce Field for Hydrocarbons. 2. Vibrational Frequencies and Thermodynamics publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00205a002 – volume: 19 start-page: 3874 year: 2012 ident: ref_12 article-title: DNA repair and resistance to topoisomerase I inhibitors: Mechanisms, biomarkers and therapeutic targets publication-title: Curr. Med. Chem. doi: 10.2174/092986712802002590 – ident: ref_62 doi: 10.1039/P29930000187 – volume: 43 start-page: 4759 year: 2000 ident: ref_50 article-title: Protein-Based Virtual Screening of Chemical Databases. 1. Evaluation of Different Docking/Scoring Combinations publication-title: J. Med. Chem. doi: 10.1021/jm001044l – volume: 32 start-page: 617 year: 2023 ident: ref_33 article-title: Recent advances on biologically active coumarin-based hybrid compounds publication-title: Med. Chem. Res. doi: 10.1007/s00044-023-03025-x – volume: 279 start-page: 55618 year: 2004 ident: ref_10 article-title: TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II publication-title: J. Biol. Chem. doi: 10.1074/jbc.M405042200 – ident: ref_31 doi: 10.3390/molecules26020501 – volume: 26 start-page: 4732 year: 2007 ident: ref_5 article-title: Spinocerebellar ataxia with axonal neuropathy: Consequence of a Tdp1 recessive neomorphic mutation? publication-title: EMBO J. doi: 10.1038/sj.emboj.7601885 – ident: ref_28 doi: 10.3390/ijms24043834 – volume: 11 start-page: 425 year: 1997 ident: ref_45 article-title: Empirical Scoring Functions: I. the Development of a Fast Empirical Scoring Function to Estimate the Binding Affinity of Ligands in Receptor Complexes publication-title: J. Comp. Aid. Mol. Design doi: 10.1023/A:1007996124545 – ident: ref_34 doi: 10.20944/preprints202209.0330.v1 – ident: ref_58 – volume: 81 start-page: 456 year: 2020 ident: ref_37 article-title: Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profile publication-title: Drug Dev. Res. doi: 10.1002/ddr.21639 – ident: ref_38 doi: 10.3390/molecules26195999 – ident: ref_40 doi: 10.3390/molecules28062673 – volume: 111 start-page: 8576 year: 1989 ident: ref_61 article-title: Molecular Mechanics. the MM3 Force Field for Hydrocarbons. 3. The Van Der Waals’ Potentials and Crystal Data for Aliphatic and Aromatic Hydrocarbons publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00205a003 – volume: 18 start-page: e202200593 year: 2023 ident: ref_4 article-title: Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors publication-title: Chem. Med. Chem. doi: 10.1002/cmdc.202200593 – ident: ref_43 doi: 10.3390/biom11070973 – volume: 46 start-page: 494 year: 2014 ident: ref_1 article-title: Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically in-duced DNA adducts and its potential as a therapeutic target publication-title: Drug Metab. Rev. doi: 10.3109/03602532.2014.971957 – volume: 19 start-page: 114 year: 2014 ident: ref_3 article-title: Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2) publication-title: DNA Repair (Amst). doi: 10.1016/j.dnarep.2014.03.020 – volume: 8 start-page: 604732 year: 2020 ident: ref_54 article-title: Human Tyrosyl-DNA Phosphodiesterase 1 Possesses Transphosphooligonucleotidation Activity With Primary Alcohols publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2020.604732 – volume: 49 start-page: 84 year: 2009 ident: ref_47 article-title: Empirical Scoring Functions for Advanced Protein−Ligand Docking with PLANTS publication-title: J. Chem. Inf. Model. doi: 10.1021/ci800298z – volume: 8 start-page: 760 year: 2009 ident: ref_9 article-title: Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin publication-title: DNA Repair. doi: 10.1016/j.dnarep.2009.02.002 – volume: 372 start-page: 1070 year: 2007 ident: ref_6 article-title: Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2007.07.055 – volume: 4 start-page: 334 year: 2023 ident: ref_20 article-title: Identification of multidentate tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors that simultaneously access the DNA, protein and catalytic-binding sites by oxime diversification publication-title: RSC Chem. Biol. doi: 10.1039/D2CB00230B – volume: 73 start-page: 128909 year: 2022 ident: ref_26 article-title: Monoterpene substituted thiazolidin-4-ones as novel TDP1 inhibitors: Synthesis, biological evaluation and docking publication-title: Bioorganic Med. Chem. Lett. doi: 10.1016/j.bmcl.2022.128909 – volume: 61 start-page: 272 year: 2005 ident: ref_48 article-title: General and Targeted Statistical Potentials for Protein–ligand Interactions publication-title: Proteins doi: 10.1002/prot.20588 – volume: 79 start-page: 2961 year: 2016 ident: ref_51 article-title: Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin publication-title: J. Nat. Prod. doi: 10.1021/acs.jnatprod.6b00979 – volume: 23 start-page: 2044 year: 2015 ident: ref_41 article-title: Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2015.03.020 – volume: 93 start-page: 11534 year: 1996 ident: ref_2 article-title: A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.93.21.11534 – volume: 10 start-page: 980 year: 2003 ident: ref_57 article-title: Announcing the Worldwide Protein Data Bank publication-title: Nat. Struct. Biol. doi: 10.1038/nsb1203-980 – ident: ref_32 doi: 10.3390/molecules28052413 – volume: 37 start-page: 1800068 year: 2018 ident: ref_53 article-title: The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening publication-title: Mol. Inf. – ident: ref_35 doi: 10.3390/ijms24043799 – ident: ref_30 doi: 10.3390/ijms21010126 – ident: ref_36 doi: 10.3390/molecules26216755 – volume: 31 start-page: 847 year: 2012 ident: ref_52 article-title: Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study publication-title: Mol. Inf. doi: 10.1002/minf.201200103 – ident: ref_39 doi: 10.3390/molecules26247493 – volume: 27 start-page: 445 year: 2008 ident: ref_64 article-title: Benchmarking the Reliability of QikProp. Correlation between Experimental and Predicted Values publication-title: QSAR Comb. Sci. doi: 10.1002/qsar.200730051 – volume: 166 start-page: 661 year: 2019 ident: ref_16 article-title: Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma publication-title: Bull. Exp. Biol. Med. doi: 10.1007/s10517-019-04413-3 – ident: ref_23 doi: 10.3390/molecules25153496 – volume: 267 start-page: 727 year: 1997 ident: ref_44 article-title: Development and Validation of a Genetic Algorithm for Flexible Docking publication-title: J. Mol. Biol. doi: 10.1006/jmbi.1996.0897 – ident: ref_63 – volume: 111 start-page: 8551 year: 1989 ident: ref_59 article-title: Molecular Mechnics. The MM3 Force Filed for Hydrocarbons. 1 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00205a001 – volume: 161 start-page: 581 year: 2019 ident: ref_15 article-title: Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2018.10.055 – ident: ref_25 doi: 10.3390/molecules26113128 – ident: ref_24 doi: 10.3390/molecules23102468 – volume: 65 start-page: 55 year: 1983 ident: ref_55 article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays publication-title: J. Immunol. Methods doi: 10.1016/0022-1759(83)90303-4 – volume: 24 start-page: 5573 year: 2016 ident: ref_29 article-title: New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2016.09.016 – volume: 26 start-page: 4720 year: 2007 ident: ref_8 article-title: TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo publication-title: EMBO J. doi: 10.1038/sj.emboj.7601869 – volume: 24 start-page: 2224 year: 2005 ident: ref_7 article-title: SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivity publication-title: EMBO J. doi: 10.1038/sj.emboj.7600694 – volume: 12 start-page: 3876 year: 2021 ident: ref_42 article-title: Small Molecule Microarray Identifies Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 that Simultaneously Access the Catalytic Pocket and Two Substrate Binding Sites publication-title: Chem. Sci. doi: 10.1039/D0SC05411A – volume: 53 start-page: 107 year: 2004 ident: ref_11 article-title: Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-003-0717-6 – volume: 52 start-page: 609 year: 2003 ident: ref_46 article-title: Improved Protein-Ligand Docking using GOLD publication-title: Proteins doi: 10.1002/prot.10465 – ident: ref_18 doi: 10.3390/molecules28010323 – ident: ref_22 doi: 10.3390/ijms24065781 – volume: 165 start-page: 108771 year: 2021 ident: ref_21 article-title: Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling study publication-title: Steroids doi: 10.1016/j.steroids.2020.108771 – volume: 6 start-page: 258 year: 2014 ident: ref_14 article-title: TDP1/TOP1 ratio as a promising indicator for the response of small cell lung cancer to topotecan publication-title: J. Cancer Sci. Ther. doi: 10.4172/1948-5956.1000280 – volume: 38 start-page: 431 year: 2021 ident: ref_17 article-title: The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo publication-title: Clin. Exp. Metastasis doi: 10.1007/s10585-021-10113-y – ident: ref_27 doi: 10.3390/molecules27113374 – volume: 83 start-page: 27 year: 2012 ident: ref_13 article-title: Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2011.09.021 – volume: 10 start-page: 910953 year: 2022 ident: ref_19 article-title: Phosphonic acidcontaining inhibitors of tyrosyl-DNA phosphodiesterase 1 publication-title: Front. Chem. doi: 10.3389/fchem.2022.910953 – volume: 28 start-page: 235 year: 2000 ident: ref_56 article-title: The Protein Data Bank publication-title: Nuc. Acids Res. doi: 10.1093/nar/28.1.235 |
SSID | ssj0023259 |
Score | 2.4014144 |
Snippet | Tyrosyl-DNA-phosphodiesterase 1 (TDP1) is an important enzyme in the DNA repair system. The ability of the enzyme to repair DNA damage induced by a... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 9155 |
SubjectTerms | Cancer Cancer therapies Care and treatment Chemotherapy Cytotoxicity DNA Drug therapy Drugs Ligands Toxicity Tumors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgCIkXtHHNNpCRQDwga3Gci_OEysbUITEh0Ul9i3yLGtTGZUkful_POU3aNUjw7NPUyrHPJf78fYS8h4qWo8Y246UJWZyVimntFHMO0rsIpTYlXhT-fp2Ob-Jv02Taf3BreljlNiZuArX1Br-Rn0FrEIcxFMfy8_I3Q9UoPF3tJTQekkdIXYaQrmx633CJaCOWxiEHsTTJ0w74LqDNP6t-LRpIXhzp0Qcp6e_AvJeZhqjJvTR0eUie9vUjHXUOPyIPXP2MPO4UJdfPyQKCFk3YeG0RnmI8Aqirmn2BXGXpZA3_v56zi-sR_THzzXLmEUOId5AbR6_oVT2rdIXyO_Qn4trb6s7RyWrhb-m5m88p9K2Otp5O_BLJHVT9gtxcfp2cj1mvqMBMLMMWPFBCB8NtDIlZaWdVyXWsoswoaaIyFSIReSkNHuRybXMXJVZYHtpcutLoTImX5KD2tXtNKAybCCKCjVUSR0gkB-_bam4MHrY6E5BP25damJ5uHFUv5gW0HeiCYt8FAfmws152NBv_sPuI_ilw98HTjOovEcCckMeqGGUJtNlhEvKAnA4sYdeY4fDWw0W_a5vifo0F5N1uGH-JSLTa-VVnk8o8y8OAvOoWxG7GeAQqoccOiBwslZ0BcnkPR-pqtuH0hjoPomHKj_8_rxPyBPXuEb4QiVNy0N6u3Buoilr9drP0_wB1Bw0G priority: 102 providerName: ProQuest |
Title | New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37298106 https://www.proquest.com/docview/2824047688 https://www.proquest.com/docview/2824689790 https://pubmed.ncbi.nlm.nih.gov/PMC10253161 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9NAEB_uA8EX8dvoWVZQfJDVbLJpkgeR3nm1J1w5tIW-hWR3QyNpUvsBxr_emSYNjR_gSwjsJFlmdmfml5mdAXiJHq2gHttcpMrm0k9jniQm5sageXftIFEpHRS-HvdHU_l55s2OYN9ttGHg-q_QjvpJTVf52x_fqw-44d8T4kTI_i77tlijIRJU6vwYTvHWpy16Ldt4AroNu7Zp9MODk4KuU-D_eLpjnH5X0Qc2qps_eWCQhnfhTuNJskEt-ntwZIr7cKvuLVk9gAWqL-bxUaUpUUWVlEqdFfwcrZZmkwq_X-X843jAbublejkvKZuQTiOvDbtiV8U8SzJqxMO-Uob7Jvtp2GS7KFfswuQ5QwRr2KZkk3JJZR7i4iFMh5eTixFveitwJQN7g7JIEcsILdFEx4nRcSoSGTu-igPlpH3X9dwwDRSFdEWiQ-N42tXC1mFgUpX4sfsIToqyME-A4bByUDdoGXvSoZJyyG-dCKUo7GqUBW_2TI1UU3ic-l_kEQIQEkF0KAILXrXUy7rgxj_oXpN8IloZ-DYVN8cJcE5U0Soa-B4CbtuzhQVnHUrcP6o7vJdwtF9-EQJRaUuEYoEFL9phepJy0gpTbmuafhD6oW3B43pBtDOmYGiAaNuCoLNUWgKq6t0dKbL5rro3enyoF_vi6X8y4hncdpDhlNHguGdwslltzXN0lDZJD479mY_XYPipB6fnl-ObLz0yXV5vtzt-AdF5FpE |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgQXxBtDgUWi4oBW9frtA0KhpUpoGyGRSrkZe3etuErstHaEzI_iNzIT22mMBLeed2yvdh7fjGd2BuAderSCZmxzkUqTO34a8yTRMdca4d02g0SmdFH4bOwNz52vU3e6A7-7uzBUVtnZxLWhVoWkf-QHGBo4poPOcfBpeclpahRlV7sRGo1YnOj6J4Zs5cfREfJ337KOv0wOh7ydKsClE5gV7iJFL14oB8EpTrSKU5E4seXLOJBW6tm2a4dpICmZKRIVastVthKmCgOdysSPbXzvLbiNwGuSRvnT6wDPttbD2QRiHvfc0GsK7W07NA-yi0WJYCmoHXsPAv8Ggi0k7FdpbsHe8QO43_qrbNAI2EPY0fkjuNNMsKwfwwKNJHP5sFZUDiMLKtjOcv4ZsVGxSY3fr-f8aDxg32ZFuZwVVLNId55LzUZslM-yJKNxP-w71dFX2S_NJqtFccUO9XzOME7WrCrYpFhSM4k4fwLnN3LWT2E3L3L9HBguSwstkHJi17GocR2et0qElJTc1dKAD92hRrJtb05TNuYRhjnEgmibBQbsb6iXTVuPf9C9J_5EpO34Nhm3lxZwT9Q3Kxr4Lob1pmsKA_Z6lKilsr_ccThqrUQZXcu0AW83y_QkVb7lulg1NF4Q-qFpwLNGIDY7ppRrgGJoQNATlQ0B9Q7vr-TZbN1DHP1KtL6eePH_fb2Bu8PJ2Wl0OhqfvIR7Fp45lU5Y9h7sVlcr_Qo9sip5vVYDBj9uWu_-AHZwS3k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwEB4ti0BcEG8CCxiJFQdkNY7zPCBUtlQtC9VKdKXesontqEFtUjatUPlp_DpmmrTbIMFtz544jucdf54BeIMRraAe21xkyuZukCU8TU3CjUH3Lu0wVRldFP468gfn7ueJNzmA39u7MASr3NrEjaHWpaJ_5B1MDVzbxeA47GQNLOKs1_-w-MGpgxSdtG7badQicmrWPzF9q94Pe8jrY8fpfxqfDHjTYYArN7SXuKIMI3qhXXRUSWp0konUTZxAJaFyMl9KT0ZZqOhgU6Q6Mo6npRa2jkKTqTRIJM57A24GEr8LdSmYXCV70tk0ahPo_7jvRX4Nupcysjv593mFjlNQafaWO_zbKex5xTZic88F9u_B3SZ2Zd1a2O7DgSkewK26m-X6IczRYDKPD9aaoDGqJPB2XvCP6Cc1G6_x_esZ74267GxaVotpSfhFuv9cGTZkw2Kapzm1_mHfCFO_zH8ZNl7Ny0t2YmYzhjmzYcuSjcsFFZZIikdwfi17_RgOi7IwT4HhsHLQGmk38VyHitjhfutUKEUHvUZZ8G67qbFqSp1Tx41ZjCkPsSDeZ4EFxzvqRV3i4x90b4k_MWk-zqaS5gIDrolqaMXdwMMU3_ZsYcFRixI1VrWHtxyOG4tRxVfybcHr3TA9SSi4wpSrmsYPoyCyLXhSC8RuxXT8GmJ-b0HYEpUdAdURb48U-XRTTxxjTLTEvnj2_3W9gtuocfGX4ej0OdxxcMsJReHIIzhcXq7MCwzOlunLjRYwuLhutfsDujhPrw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+5-Hydroxycoumarin-Based+Tyrosyl-DNA+Phosphodiesterase+I+Inhibitors+Sensitize+Tumor+Cell+Line+to+Topotecan&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Khomenko%2C+Tatyana+M.&rft.au=Zakharenko%2C+Alexandra+L.&rft.au=Kornienko%2C+Tatyana+E.&rft.au=Chepanova%2C+Arina+A.&rft.date=2023-05-23&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=24&rft.issue=11&rft.spage=9155&rft_id=info:doi/10.3390%2Fijms24119155&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms24119155 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |